📖

acc-chronic-pain

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-acc-chronic-pain

Related Entities

cell-types-acc-chronic-pain

Metadata

slug	cell-types-acc-chronic-pain
entity_type	cell_type
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (205)

see_also📖Ferroptosis-Sensitive Neurons60%

see_also📖Oligodendrocyte Lineage in Alzheimer's Disease60%

see_also📖Oligodendrocyte Lineage in Multiple System Atrophy60%

see_also📖Oligodendrocyte Precursor Cells60%

see_also📖Oligodendrocyte Precursor Cells in Demyelinating Disease60%

see_also📖Oligodendrocyte Precursor Cells (OPCs)60%

see_also📖Oligodendrocyte Progenitor Cells (OPCs) - Expanded60%

see_also📖Oligodendrocyte Precursor Cells in Periventricular Leukomala60%

see_also📖ATP P2X3 Receptor Neurons60%

see_also📖AMPK (AMP-Activated Protein Kinase)60%

see_also📖Ferroptosis60%

see_also📖Ferroptosis Validation in Parkinson's Disease60%

see_also📖Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%

see_also📖DLK1 Gene60%

see_also📖GAIN Gene - GABA-A Receptor Associated Protein Like 260%

see_also📖JNK1 (MAPK8)60%

see_also📖Ferroptosis Hypothesis in Parkinson's Disease60%

see_also📖Oligodendrocyte-Myelin Dysfunction Hypothesis in Parkinson&#60%

see_also📖Oligodendrocyte Precursor Cell Activation for Myelin Regener60%

see_also📖AMPK Agonist Therapy for Neurodegeneration60%

see_also📖Ferroptosis Inhibition Therapy60%

see_also📖Oligodendrocyte Protection Therapy for Neurodegeneration60%

see_also📖Ferroptosis Modulation Investment Landscape60%

see_also📖Oligodendrocyte and Myelin Dysfunction in Corticobasal Syndr60%

see_also📖Ferroptosis in Neurodegeneration60%

see_also📖ferroptosis-4r-tauopathies60%

see_also📖Ferroptosis in Alzheimer's Disease60%

see_also📖Ferroptosis Pathway in Alzheimer's Disease60%

see_also📖Ferroptosis in Alzheimer's Disease60%

see_also📖Ferroptosis and Lipid Peroxidation in 4R-Tauopathies60%

see_also📖Ferroptosis in Neurodegeneration60%

see_also📖Ferroptosis Pathway in Neurodegeneration60%

see_also📖Ferroptosis in Parkinson's Disease60%

see_also📖Ferroptosis Pathway in Neurodegeneration60%

see_also📖Oligodendrocyte Dysfunction in Neurodegeneration Pathway60%

see_also📖Oligodendrocyte Dysfunction Pathway in Neurodegeneration60%

see_also📖Oligodendrocyte-Neuron Metabolic Support Pathway in Neurodeg60%

see_also📖Oligodendrocyte Pathology in 4R-Tauopathies60%

see_also📖Oligodendrocyte Precursor Differentiation Failure in Neurode60%

see_also📖JNK (c-Jun N-terminal Kinase) Protein60%

see_also📖Ferroptosis Inhibitors60%

see_also📖Ferroptosis Modulation Therapy60%

see_also📖Ferroptosis Therapy for Parkinson's Disease60%

see_also📖Oligodendrocyte Precursor Cell Therapy60%

see_also📖ATP P2X3 Receptor Neurons60%

see_also📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

see_also📖Packard Center for ALS Research60%

see_also📖Hippocampus60%

see_also📖Hypothalamus60%

see_also📖Neurons in Dentatorubral-Pallidoluysian Atrophy60%

see_also📖Neurons in Lysosomal Storage Disorders with Neurodegeneratio60%

see_also📖Neurons60%

see_also📖Neurons — Cell Type Hierarchy60%

see_also📖Neurons in Normal Pressure Hydrocephalus60%

see_also📖Neurons in Prion Disease60%

see_also📖Neurons in Spinocerebellar Ataxia Type 3 (Machado-Joseph Dis60%

see_also📖Neurons Susceptible to Viral Infection60%

see_also📖Neurons in Wilson Disease60%

see_also📖Neurons60%

see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%

see_also📖ARNT2 - Aryl Hydrocarbon Receptor Nuclear Translocator 260%

see_also📖cd3660%

see_also📖DHCR24 Gene60%

see_also📖FAS Gene60%

see_also📖HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase60%

see_also📖LDLR Gene60%

see_also📖LPL — Lipoprotein Lipase60%

see_also📖SCD1 Gene60%

see_also📖SREBF2 — Sterol Regulatory Element Binding Transcription Fac60%

see_also📖erk-mapk-signaling-neurodegeneration60%

see_also📖FAS Protein60%

see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%

see_also📖ARNT2 - Aryl Hydrocarbon Receptor Nuclear Translocator 260%

see_also📖ULK1 — UNC-51 Like Kinase 160%

see_also📖ULK1 Protein60%

see_also📖KCNH7 Gene60%

see_also📖SHANK3 - SH3 and Multiple Ankyrin Repeat Domains 360%

see_also📖SST Gene60%

see_also📖APP Gene Dosage Reduction Therapy for Down Syndrome60%

see_also📖SPR Gene60%

see_also📖Sepiapterin Reductase (SPR)60%

related🧪Temporal Decoupling via Circadian Clock Reset55%

related🧪Netrin-1 Gradient Restoration55%

related🧪Purinergic Signaling Polarization Control55%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 55%

related🧪Circadian-Synchronized Proteostasis Enhancement55%

related🧪Mitochondrial SPM Synthesis Platform Engineering55%

related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective55%

related🧪APOE-TREM2 Interaction Modulation55%

related🧪Arginine Methylation Enhancement Therapy55%

related🧪Senescent Cell Mitochondrial DNA Release55%

related🧪SASP-Mediated Cholinergic Synapse Disruption55%

related🧪Multi-Modal Stress Response Harmonization55%

related🧪Complement C1q Mimetic Decoy Therapy55%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu55%

related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted55%

related🧪Liquid-Liquid Phase Separation Modifier Therapy55%

related🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor55%

related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu55%

related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar55%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi55%

related🧪Noradrenergic-Tau Propagation Blockade55%

related🧪Adenosine-Astrocyte Metabolic Reset55%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho55%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists55%

related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy55%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations55%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation55%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics55%

related🧪APOE-Dependent Autophagy Restoration55%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem55%

related🧪Complement C1q Subtype Switching55%

related🧪Proteostasis Enhancement via APOE Chaperone Targeting55%

related🧪Microglial Purinergic Reprogramming55%

related🧪Autophagosome Maturation Checkpoint Control55%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener55%

related🧪TREM2-Dependent Microglial Senescence Transition55%

related🧪Prefrontal sensory gating circuit restoration via PV interne55%

related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub55%

related🧪PARP1 Inhibition Therapy55%

related🧪Low Complexity Domain Cross-Linking Inhibition55%

related🧪Ocular Immune Privilege Extension55%

related🧪Hypocretin-Neurogenesis Coupling Therapy55%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu55%

related🧪Synaptic Vesicle Tau Capture Inhibition55%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor55%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset55%

related🧪Piezoelectric Nanochannel BBB Disruption55%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis55%

related🧪Lipid Droplet Dynamics as Phenotype Switches55%

related🧪Glycine-Rich Domain Competitive Inhibition55%

related🧪SASP-Driven Aquaporin-4 Dysregulation55%

related🧪Optogenetic Control of Mitochondrial Transfer Networks55%

related🧪Circadian-Gated Maresin Biosynthesis Amplification55%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming55%

related🧪Orexin-Microglia Modulation Therapy55%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation55%

related🧪Lysosomal Membrane Repair Enhancement55%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement55%

related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy55%

related🧪Blood-Brain Barrier SPM Shuttle System55%

related🧪Stress Granule Phase Separation Modulators55%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction55%

related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR55%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto55%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu55%

related🧪Flotillin-1 Stabilization Compounds55%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy55%

related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A55%

related🧪HDAC3-Selective Inhibition for Clock Reset55%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering55%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati55%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation55%

related🧪TREM2-mediated microglial tau clearance enhancement55%

related🧪Lysosomal Enzyme Trafficking Correction55%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides55%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri55%

related🧪Glial Glycocalyx Remodeling Therapy55%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy55%

related🧪Senescence-Activated NAD+ Depletion Rescue55%

related🧪Epigenetic Memory Erasure via TET2 Activation55%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol55%

related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste55%

related🧪Mechanosensitive Ion Channel Reprogramming55%

related🧪Serine/Arginine-Rich Protein Kinase Modulation55%

related🧪Selective Acid Sphingomyelinase Modulation Therapy55%

related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)55%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme55%

related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon55%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors55%

related🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction55%

related🧪Ephrin-B2/EphB4 Axis Manipulation55%

related🧪Phase-Separated Organelle Targeting55%

related🧪Vagal Afferent Microbial Signal Modulation55%

related🧪Cross-Seeding Prevention Strategy55%

related🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam55%

related🧪Purinergic P2Y12 Inverse Agonist Therapy55%

related🧪Trans-Synaptic Adhesion Molecule Modulation55%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation55%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation55%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna55%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition55%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization55%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

related🧪Senescent Cell Mitochondrial DNA Release40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%

related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%

related🔬Analyze circuit-level changes in neurodegeneration using All32%

related🔬What are the mechanisms underlying selective vulnerability o30%